AngioDynamics to Present at the 2015 Canaccord Genuity Medical Technology & Diagnostics Forum

November 11, 2015 at 6:30 AM EST

ALBANY, N.Y., Nov. 11, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 19, 2015, at 3:00 p.m. ET.  The conference will be held in New York City, NY.

A live audio and/or webcast and subsequent archived replay of AngioDynamics' presentation may be accessed via the investor relations section of the Company's website under "Events & Presentations" at http://investors.angiodynamics.com/events.cfm. The replay will be available for 90 days after the event.

About AngioDynamics

AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.

Trademarks
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.

Company Contact:



AngioDynamics, Inc.Caitlin Stefanik

(518) 795-1418

cstefanik@angiodynamics.com



Investor Relations Contact:



EVC Group, Inc.Chris Dailey

(212) 850-6020

cdailey@evcgroup.com;



Media Contact:



EVC Group, Inc.Dave Schemelia

(646) 201-5431

dave@evcgroup.com

Primary Logo

Source: AngioDynamics

News Provided by Acquire Media